China Pharma Holdings, Inc.

NYSEAM:CPHI Stock Report

Market Cap: US$3.4m

China Pharma Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Zhilin Li

Chief executive officer

US$241.6k

Total compensation

CEO salary percentage93.4%
CEO tenure19.2yrs
CEO ownership15.7%
Management average tenureno data
Board average tenure16.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Zhilin Li's remuneration changed compared to China Pharma Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$5m

Jun 30 2024n/an/a

-US$4m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$242kUS$226k

-US$3m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$3m

Mar 31 2023n/an/a

-US$3m

Dec 31 2022US$2kUS$226k

-US$4m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$4m

Mar 31 2022n/an/a

-US$4m

Dec 31 2021US$242kUS$226k

-US$3m

Sep 30 2021n/an/a

-US$4m

Jun 30 2021n/an/a

-US$4m

Mar 31 2021n/an/a

-US$3m

Dec 31 2020US$242kUS$226k

-US$3m

Sep 30 2020n/an/a

-US$20m

Jun 30 2020n/an/a

-US$20m

Mar 31 2020n/an/a

-US$21m

Dec 31 2019US$242kUS$226k

-US$21m

Sep 30 2019n/an/a

-US$10m

Jun 30 2019n/an/a

-US$11m

Mar 31 2019n/an/a

-US$11m

Dec 31 2018US$242kUS$226k

-US$11m

Sep 30 2018n/an/a

-US$17m

Jun 30 2018n/an/a

-US$17m

Mar 31 2018n/an/a

-US$19m

Dec 31 2017US$242kUS$226k

-US$19m

Compensation vs Market: Zhilin's total compensation ($USD241.60K) is below average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Zhilin's compensation has increased whilst the company is unprofitable.


CEO

Zhilin Li (71 yo)

19.2yrs

Tenure

US$241,600

Compensation

Ms. Zhilin Li has been the Chief Executive Officer and President of China Pharma Holdings, Inc. since October 20, 2005 and has serves as its Interim Chief Financial Officer. Ms. Li is Founder of Helpson Bi...


Board Members

NamePositionTenureCompensationOwnership
Zhilin Li
President18.9yrsUS$241.60k15.73%
$ 526.8k
Gene Bennett
Independent Director16.8yrsUS$16.00kno data
Heung Mei Tsui
Director15.7yrsUS$16.00k0.97%
$ 32.4k
Baowen Dong
Independent Director16.8yrsUS$6.20kno data
Yingwen Zhang
Independent Director16.8yrsUS$6.20kno data

16.8yrs

Average Tenure

76yo

Average Age

Experienced Board: CPHI's board of directors are seasoned and experienced ( 16.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:01
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Pharma Holdings, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin DeGeeterLadenburg Thalmann & Company
Reni BenjaminRodman & Renshaw, LLC
Scott HenryRoth MKM